A
Aquestive Therapeutics Inc
NASDAQ:AQST
Aquestive Therapeutics Inc
NASDAQ:AQST
Price:
3.1 USD
1.31%
Market Closed
Updated:
May 29, 2024
Aquestive Therapeutics Inc
Cash Interest Paid
|
Aquestive Therapeutics Inc
Cash Interest Paid Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Aquestive Therapeutics Inc
NASDAQ:AQST
|
Cash Interest Paid
$4.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash Interest Paid
$308m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Cash Interest Paid
$2.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Cash Interest Paid
$1.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash Interest Paid
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aquestive Therapeutics Inc's Cash Interest Paid?
Cash Interest Paid
4.1m
USD
4.1m
USD
Based on the financial report for Mar 31, 2024, Aquestive Therapeutics Inc's Cash Interest Paid amounts to 4.1m USD.
What is Aquestive Therapeutics Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
-6%
-6%
Over the last year, the Cash Interest Paid growth was -34%. The average annual Cash Interest Paid growth rates for Aquestive Therapeutics Inc have been -19% over the past three years , -6% over the past five years .
You don't have any saved screeners yet
